June Carl Howard Buys Shares of ACIU
June Carl Howard purchased 38,889 shares of ACIU on June 11, 2026.
Key Points
- June Carl Howard purchased 38,889 shares of ACIU on June 11, 2026, reflecting a strategic buy.
- ACIU shares are trading at $2.31 with a focus from institutional investors like BlackRock, Inc. and Renaissance Technologies LLC.
- Analysts from BTIG and HC Wainwright maintain a buy rating with price targets up to $16.00.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
June Carl Howard made a notable move by purchasing 38,889 shares of ACIU on June 11, 2026. This insider transaction did not involve a pre-planned trading arrangement, indicating a direct interest in the company's stock.
Insider Buying and Selling at AC Immune SA
On June 11, 2026, several insiders took part in buying ACIU shares. Notably, June Carl Howard acquired 38,889 shares. Meanwhile, other insiders like Renee Aguiar-Lucander and Monika Buetler also made purchases of varying amounts on the same day, showing a concerted effort among company insiders to increase their stakes.
Other Institutional Activity in ACIU
Institutional investors have shown varied interest in ACIU. BVF Inc/IL maintained its position with 19,822,436 shares valued at approximately $54.5 million. Wells Fargo & Company/MN reduced its holdings by 2,005 shares, ending with 1,004,284 shares worth about $2.76 million. Millennium Management LLC significantly trimmed its position by 140,685 shares, now holding 792,657 shares valued at around $2.18 million. On the other hand, BlackRock, Inc. increased its stake by 22,109 shares, totaling 524,278 shares valued at roughly $1.44 million.
AC Immune SA Stock Down 11.3%
ACIU shares are trading at $2.31. While specific financial ratios and metrics are not available, the stock's recent activity and interest from both insiders and institutional investors indicate active engagement with the market.
Analysts Set New Price Targets
Analysts are optimistic about ACIU's prospects. On March 16, 2026, BTIG reiterated its buy rating with a price target of $8.00. HC Wainwright & Co. maintained a buy rating with a higher target of $12.00 as of May 1, 2025. These ratings reflect continued confidence in ACIU's potential.
Bottom Line
The recent insider buying activity by June Carl Howard and others suggests internal optimism at ACIU. Institutional investors have shown mixed reactions, with some increasing and others decreasing their stakes. Analysts remain bullish, maintaining buy ratings with targets as high as $16.00. As always, these insights are based on past data and may not reflect current market dynamics.
Get AC Immune SA alerts
New 13F filings, insider trades, and analyst moves on $ACIU, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.